132 related articles for article (PubMed ID: 22155224)
41. Systems and network biology in pharmaceutical drug discovery.
Azmi AS
Curr Pharm Des; 2014; 20(1):2-3. PubMed ID: 23530505
[No Abstract] [Full Text] [Related]
42. Ecopharmacology: a new topic of importance in pharmacovigilance.
Kümmerer K; Velo G
Drug Saf; 2006; 29(5):371-3. PubMed ID: 16689553
[No Abstract] [Full Text] [Related]
43. Quantitative assessment of biological impact using transcriptomic data and mechanistic network models.
Thomson TM; Sewer A; Martin F; Belcastro V; Frushour BP; Gebel S; Park J; Schlage WK; Talikka M; Vasilyev DM; Westra JW; Hoeng J; Peitsch MC
Toxicol Appl Pharmacol; 2013 Nov; 272(3):863-78. PubMed ID: 23933166
[TBL] [Abstract][Full Text] [Related]
44. Assessment of network perturbation amplitudes by applying high-throughput data to causal biological networks.
Martin F; Thomson TM; Sewer A; Drubin DA; Mathis C; Weisensee D; Pratt D; Hoeng J; Peitsch MC
BMC Syst Biol; 2012 May; 6():54. PubMed ID: 22651900
[TBL] [Abstract][Full Text] [Related]
45. Causal biological network database: a comprehensive platform of causal biological network models focused on the pulmonary and vascular systems.
Boué S; Talikka M; Westra JW; Hayes W; Di Fabio A; Park J; Schlage WK; Sewer A; Fields B; Ansari S; Martin F; Veljkovic E; Kenney R; Peitsch MC; Hoeng J
Database (Oxford); 2015; 2015():bav030. PubMed ID: 25887162
[TBL] [Abstract][Full Text] [Related]
46. A 7-month cigarette smoke inhalation study in C57BL/6 mice demonstrates reduced lung inflammation and emphysema following smoking cessation or aerosol exposure from a prototypic modified risk tobacco product.
Phillips B; Veljkovic E; Peck MJ; Buettner A; Elamin A; Guedj E; Vuillaume G; Ivanov NV; Martin F; Boué S; Schlage WK; Schneider T; Titz B; Talikka M; Vanscheeuwijck P; Hoeng J; Peitsch MC
Food Chem Toxicol; 2015 Jun; 80():328-345. PubMed ID: 25843363
[TBL] [Abstract][Full Text] [Related]
47. Nicotine Population Pharmacokinetics in Healthy Adult Smokers: A Retrospective Analysis.
Marchand M; Brossard P; Merdjan H; Lama N; Weitkunat R; Lüdicke F
Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):943-954. PubMed ID: 28283988
[TBL] [Abstract][Full Text] [Related]
48. Effects of Switching to the Tobacco Heating System 2.2 Menthol, Smoking Abstinence, or Continued Cigarette Smoking on Biomarkers of Exposure: A Randomized, Controlled, Open-Label, Multicenter Study in Sequential Confinement and Ambulatory Settings (Part 1).
Lüdicke F; Picavet P; Baker G; Haziza C; Poux V; Lama N; Weitkunat R
Nicotine Tob Res; 2018 Jan; 20(2):161-172. PubMed ID: 28177489
[TBL] [Abstract][Full Text] [Related]
49. Comparative systems toxicology analysis of cigarette smoke and aerosol from a candidate modified risk tobacco product in organotypic human gingival epithelial cultures: A 3-day repeated exposure study.
Zanetti F; Titz B; Sewer A; Lo Sasso G; Scotti E; Schlage WK; Mathis C; Leroy P; Majeed S; Torres LO; Keppler BR; Elamin A; Trivedi K; Guedj E; Martin F; Frentzel S; Ivanov NV; Peitsch MC; Hoeng J
Food Chem Toxicol; 2017 Mar; 101():15-35. PubMed ID: 28025120
[TBL] [Abstract][Full Text] [Related]
50. Biomarker of exposure level data set in smokers switching from conventional cigarettes to Tobacco Heating System 2.2, continuing smoking or abstaining from smoking for 5 days.
Haziza C; de La Bourdonnaye G; Skiada D; Ancerewicz J; Baker G; Picavet P; Lüdicke F
Data Brief; 2017 Feb; 10():283-293. PubMed ID: 27995164
[TBL] [Abstract][Full Text] [Related]
51. 3-D nasal cultures: Systems toxicological assessment of a candidate modified-risk tobacco product.
Iskandar AR; Mathis C; Martin F; Leroy P; Sewer A; Majeed S; Kuehn D; Trivedi K; Grandolfo D; Cabanski M; Guedj E; Merg C; Frentzel S; Ivanov NV; Peitsch MC; Hoeng J
ALTEX; 2017; 34(1):23-48. PubMed ID: 27388676
[TBL] [Abstract][Full Text] [Related]
52. Reputation-based collaborative network biology.
; Binder J; Boue S; Di Fabio A; Fields RB; Hayes W; Hoeng J; Park JS; Peitsch MC
Pac Symp Biocomput; 2015; ():270-81. PubMed ID: 25592588
[TBL] [Abstract][Full Text] [Related]
53. Quantification of biological network perturbations for mechanistic insight and diagnostics using two-layer causal models.
Martin F; Sewer A; Talikka M; Xiang Y; Hoeng J; Peitsch MC
BMC Bioinformatics; 2014 Jul; 15():238. PubMed ID: 25015298
[TBL] [Abstract][Full Text] [Related]
54. Case study: the role of mechanistic network models in systems toxicology.
Hoeng J; Talikka M; Martin F; Sewer A; Yang X; Iskandar A; Schlage WK; Peitsch MC
Drug Discov Today; 2014 Feb; 19(2):183-92. PubMed ID: 23933191
[TBL] [Abstract][Full Text] [Related]
55. Enhancement of COPD biological networks using a web-based collaboration interface.
; Boue S; Fields B; Hoeng J; Park J; Peitsch MC; Schlage WK; Talikka M; ; Binenbaum I; Bondarenko V; Bulgakov OV; Cherkasova V; Diaz-Diaz N; Fedorova L; Guryanova S; Guzova J; Igorevna Koroleva G; Kozhemyakina E; Kumar R; Lavid N; Lu Q; Menon S; Ouliel Y; Peterson SC; Prokhorov A; Sanders E; Schrier S; Schwaitzer Neta G; Shvydchenko I; Tallam A; Villa-Fombuena G; Wu J; Yudkevich I; Zelikman M
F1000Res; 2015; 4():32. PubMed ID: 25767696
[TBL] [Abstract][Full Text] [Related]
56. A crowd-sourcing approach for the construction of species-specific cell signaling networks.
Bilal E; Sakellaropoulos T; Melas IN; Messinis DE; Belcastro V; Rhrissorrakrai K; Meyer P; Norel R; Iskandar A; Blaese E; Rice JJ; Peitsch MC; Hoeng J; Stolovitzky G; Alexopoulos LG; Poussin C;
Bioinformatics; 2015 Feb; 31(4):484-91. PubMed ID: 25294919
[TBL] [Abstract][Full Text] [Related]
57. In vitro systems toxicology approach to investigate the effects of repeated cigarette smoke exposure on human buccal and gingival organotypic epithelial tissue cultures.
Schlage WK; Iskandar AR; Kostadinova R; Xiang Y; Sewer A; Majeed S; Kuehn D; Frentzel S; Talikka M; Geertz M; Mathis C; Ivanov N; Hoeng J; Peitsch MC
Toxicol Mech Methods; 2014 Oct; 24(7):470-87. PubMed ID: 25046638
[TBL] [Abstract][Full Text] [Related]
58. Systems approaches evaluating the perturbation of xenobiotic metabolism in response to cigarette smoke exposure in nasal and bronchial tissues.
Iskandar AR; Martin F; Talikka M; Schlage WK; Kostadinova R; Mathis C; Hoeng J; Peitsch MC
Biomed Res Int; 2013; 2013():512086. PubMed ID: 24224167
[TBL] [Abstract][Full Text] [Related]
59. On Crowd-verification of Biological Networks.
; Ansari S; Binder J; Boue S; Di Fabio A; Hayes W; Hoeng J; Iskandar A; Kleiman R; Norel R; O'Neel B; Peitsch MC; Poussin C; Pratt D; Rhrissorrakrai K; Schlage WK; Stolovitzky G; Talikka M
Bioinform Biol Insights; 2013; 7():307-25. PubMed ID: 24151423
[TBL] [Abstract][Full Text] [Related]
60. Strengths and limitations of microarray-based phenotype prediction: lessons learned from the IMPROVER Diagnostic Signature Challenge.
Tarca AL; Lauria M; Unger M; Bilal E; Boue S; Kumar Dey K; Hoeng J; Koeppl H; Martin F; Meyer P; Nandy P; Norel R; Peitsch M; Rice JJ; Romero R; Stolovitzky G; Talikka M; Xiang Y; Zechner C;
Bioinformatics; 2013 Nov; 29(22):2892-9. PubMed ID: 23966112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
